Clinical Trial Update: wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing wXELIRI vs FOLFIRI regimens in advanced colorectal cancer; the update does not specify trial results or status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN